Home > Boards > US Listed > Biotechs > vTv Therapeutics (VTVT)

VtV Therapeutics In Breakout zone today, up premarket.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
TopMarketGainers Member Profile
Member Level 
Followed By 29
Posts 1,022
Boards Moderated 1
Alias Born 04/28/19
160x600 placeholder
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 10/15/2019 7:16:00 AM
vTv to Host Key Opinion Leader Event to Discuss the Type 1 Diabetes Treatment Landscape and Emerging Therapies as Adjuncts to... GlobeNewswire Inc. - 10/3/2019 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/30/2019 4:53:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/27/2019 4:31:57 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 9/27/2019 4:26:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/18/2019 4:41:24 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 9/18/2019 4:41:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/18/2019 4:31:15 PM
vTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study in Patients with Type 1 Diabetes at 55t... GlobeNewswire Inc. - 9/18/2019 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2019 4:31:42 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/17/2019 4:30:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2019 7:00:25 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 4:43:02 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 9/11/2019 4:39:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/11/2019 4:31:12 PM
vTv Therapeutics to Present Posters at Two Scientific Conferences in September GlobeNewswire Inc. - 9/11/2019 7:30:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 9/5/2019 6:01:06 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/4/2019 6:25:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/4/2019 4:59:23 PM
vTv Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire Inc. - 9/4/2019 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/22/2019 6:38:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/19/2019 7:39:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/6/2019 4:41:44 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 8/6/2019 4:31:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2019 4:31:15 PM
TopMarketGainers Member Level  Tuesday, 04/30/19 07:30:02 PM
Re: None
Post # of 454 
Compensated Awareness Post - View Disclaimer
VtV Therapeutics In Breakout zone today, up premarket.

Highly speculative but has engaged our interest with volume and price spikes over the course of the last week. Up again today premarket and rumor mill is very active as is the case with many Bio-Pharm space.On the watchlist for breakout.


Company Description
vTv Therapeutics , Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC .



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist